The Leaf Index
Vol. IA field guide to cannabis cultivarsleafly.cc
No. 6405Indica

Daves Who 13 by James Loud Genetics

Dave's Who 13, a cultivar from James Loud Genetics, is characterized by its sativa-leaning genetics, offering a mentally uplifting experience. Bred with a focus on rigorous selection, this strain aims for high terpene expression and functional effects, appealing to consumers seeking daytime clarity.

May help withStress
AromaCitrusFloralHerbalLemonMangoOrangePepperyPine

Appearance

Dave's Who 13 typically exhibits a sativa-dominant structure, with plants showing medium vigor during vegetative growth and accelerating rapidly once established. Leaflets are generally narrow to medium in width. During flowering, buds often form as elongated spears with stacked calyxes that swell significantly in the later stages. The plant's internodal spacing allows for good airflow, and it responds well to training techniques like topping and low-stress training (LST) to develop a broader canopy with multiple colas.

Resin production is notable, with trichomes appearing by mid-flower and frosting sugar leaves early. While mild foxtailing can occur under specific conditions like high temperatures or excessive light intensity, the overall structure is described as elegant and orderly when managed with consistent feeding and training. The calyx-to-leaf ratio is generally favorable, simplifying trim work.

Aroma and Flavor

The aroma of Dave's Who 13 is complex, developing significantly after the fourth week of bloom. Growers commonly report a dominant profile of bright lemon or mixed citrus peel, often complemented by notes of green pine and fresh herbs. Secondary nuances may include floral hints, sweet melon, or a subtle tropical aroma reminiscent of mango skin. Stem rubs can reveal sharper pine-solvent facets that mature into sweeter tones during the curing process.

The flavor profile mirrors the aroma, presenting a combination of citrus and herbal notes. Depending on the specific terpene expression, hints of floral sweetness, peppery undertones, or tropical fruit may also be detected. This aromatic complexity suggests a rich chemical profile that contributes to its overall sensory experience.

Effects

Dave's Who 13 is frequently described as providing a rapid-onset, mentally lifting experience with an energetic push. Early reports highlight its ability to promote clarity rather than sedation, aligning with its sativa-leaning heritage. The effects are often characterized as functional and creative, making it suitable for daytime use for consumers who prefer an alert state.

This strain is reported to help with stress, offering a mental uplift that can be beneficial for managing daily pressures. The energetic and creative qualities may appeal to individuals looking for inspiration or a boost in productivity without the heavy sedation sometimes associated with indica-dominant strains.

Terpenes and Cannabinoids

While specific cannabinoid percentages are not always consistent, Dave's Who 13 generally falls within the 19-22% THC range, with CBD levels below 1%. The terpene profile is noted for its complexity, often leaning towards monoterpenes that contribute to bright aromas. Commonly observed terpenes include Limonene, Caryophyllene, Linalool, Pinene, Terpinolene, and Ocimene. These contribute to the strain's citrus, herbal, floral, and piney aromatic qualities.

The combination of these terpenes and cannabinoids is thought to contribute to the strain's reported effects, such as mental clarity and creative stimulation. The breeder, James Loud Genetics, is known for targeting high-terpene profiles in their modern hybrid selections, suggesting a deliberate focus on the aromatic and potential therapeutic qualities of their cultivars.

Growing

Dave's Who 13 is considered a sativa-dominant hybrid, and its cultivation reflects this heritage. It exhibits medium vigor during vegetative stages and accelerates rapidly once established. Growers report a pronounced vertical stretch during the transition to flowering, typically between 1.8x to 2.4x when flipped at heights of 12-16 inches. This trait necessitates attention to canopy management, with techniques like topping and low-stress training (LST) recommended.

The flowering period is generally moderate, with buds forming as elongated spears. The plant responds well to training, supporting multiple mid-sized colas for uniform ripening. Optimal conditions include good airflow and moderate internodal spacing. Environmental tuning is important to manage potential foxtailing under high PPFD or excessive heat. The breeder's focus on vigorous growth and resin production suggests a cultivar that, with proper care, can yield well.

Origins and Lineage

Dave's Who 13 was bred by James Loud Genetics, a California-based breeder recognized for their rigorous phenotype selection and development of modern hybrids with high terpene content. The '13' in the strain name likely signifies a specific keeper phenotype selected from a larger breeding project, a common practice in breeder circles to identify standout expressions from wide seed runs.

The exact parental lineage of Dave's Who 13 has not been publicly disclosed by the breeder. However, its traits are strongly associated with sativa-forward lines, potentially drawing from Haze-like or tropical sativa families, indicated by its growth structure and terpene profile. James Loud Genetics typically aims for market-ready chemovars with strong resin production, vigorous growth, and functional, creative effects.

Frequently asked questions

What is the THC and CBD content of Dave's Who 13?
Dave's Who 13 typically contains 19-22% THC and less than 1% CBD.
What are the dominant aromas and flavors of Dave's Who 13?
The strain is known for complex aromas and flavors, often featuring bright lemon and mixed citrus notes, complemented by herbal, pine, and sometimes floral or tropical undertones.
What kind of effects can I expect from Dave's Who 13?
Users report mentally uplifting, energetic, and creative effects, making it suitable for daytime use and potentially helpful for stress.
Who developed Dave's Who 13?
Dave's Who 13 was developed by James Loud Genetics, a breeder known for selecting high-terpene modern hybrids.